Jump to top menu Jump to main menu Jump to content
Profile picture of Carolien van Deurzen
Research group/lab

Group Van Deurzen

We aim to understand breast cancer progression and treatment response by studying both cancer cells and the micro-environment.

About our research group/lab

Our research

Our main research subjects are:

  • Subtype-specific characteristics of ductal carcinoma in situ of the breast, aiming to optimize treatment decisions
  • Triple negative breast cancer: predictors of treatment response and seeking for treatment targets for those patients with poor response to neoadjuvant chemotherapy 
  • HER2-low breast cancer: optimizing diagnostics to select patients with potential benefit from novel therapies.  

Key Publications

Funding & Grants

2013-2017: Fellowship Erasmus MC

2015: Male breast cancer characteristics, Breast Cancer Research Foundation (BCRF)

2016: Micro-environment across subtypes of ductal carcinoma in situ of the breast,


2018: Role of tumor infiltrating lymfocytes during breast carcinogenesis, Aspasia,


2021: Seeking for treatment targets for TNBC patients with poor response on

neoadjuvant treatment, Roche

2021: HER2-low breast cancer, Astrazeneca

Our team

Nadine van den Ende, PhD student

Ximena Baez Navarro, PhD student